IMMUNOME INC
IMNMNASDAQ🏆 #1833 by market capEarnings Nov 16US Equity
$18.29▼ $0.47 (−2.51%)
🌙 After hours$18.29▲ 0.00%Regular close · extended-hours price shownTrack IMNM
Get earnings, price moves & breaking news on Telegram
24h▼ 2.5%
7d▲ 1.6%
14d▲ 11.1%
30d▼ 15.0%
ytd▼ 14.9%
1y▲ 14.7%
🏦Market Cap
$2.16B
Small Cap
📈Revenue Growth (YoY)
-23.2%
Declining
📊Gross Margin
0.0%
Thin
💵FCF Margin
0.0%
Thin
⚖️P/S Ratio
0.0x
Cheap
Otter Score
36
Weak
IMMUNOME INC
IMNMAnalyst Ratings
Price
$18.29
Total
13
Raised
0
Lowered
0
Avg PT
$33.00
H / L
$37 / $24
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Wedbush | Reiterated | Outperform | 2026-10-27 | $35.00 | +91.40% |
HC Wainwright & Co. | Reiterated | Buy | 2026-09-10 | — | — |
Truist Securities | Reiterated | Buy | 2026-08-12 | — | — |
Leerink Partners | Reiterated | Outperform | 2026-05-15 | $33.00 | +80.40% |
Craig-Hallum | Reiterated | Buy | 2026-03-04 | $26.00 | +42.20% |
Stephens & Co. | Reiterated | Overweight | 2026-03-04 | — | — |
Lake Street | Reiterated | Buy | 2025-12-16 | $32.00 | +75.00% |
Evercore ISI Group | Reiterated | Outperform | 2025-12-16 | — | — |
Guggenheim | Reiterated | Buy | 2025-12-16 | $35.00 | +91.40% |
JP Morgan | Reiterated | Overweight | 2025-08-07 | — | — |
Piper Sandler | Reiterated | Overweight | 2024-11-14 | $23.00 | +25.80% |
Cantor Fitzgerald | Reiterated | Overweight | 2023-03-20 | — | — |
Chardan Capital | Reiterated | Buy | 2023-03-17 | — | — |
Institution
Wedbush
Reiterated · Outperform · 2026-10-27
$35.00
+91.40%
HC Wainwright & Co.
Reiterated · Buy · 2026-09-10
—
—
Truist Securities
Reiterated · Buy · 2026-08-12
—
—
Leerink Partners
Reiterated · Outperform · 2026-05-15
$33.00
+80.40%
Craig-Hallum
Reiterated · Buy · 2026-03-04
$26.00
+42.20%
Stephens & Co.
Reiterated · Overweight · 2026-03-04
—
—
Lake Street
Reiterated · Buy · 2025-12-16
$32.00
+75.00%
Evercore ISI Group
Reiterated · Outperform · 2025-12-16
—
—
Guggenheim
Reiterated · Buy · 2025-12-16
$35.00
+91.40%
JP Morgan
Reiterated · Overweight · 2025-08-07
—
—
Piper Sandler
Reiterated · Overweight · 2024-11-14
$23.00
+25.80%
Cantor Fitzgerald
Reiterated · Overweight · 2023-03-20
—
—
Chardan Capital
Reiterated · Buy · 2023-03-17
—
—
One row per institution · price target from the firm's latest published target